Kedziora-Kornatowska, K
The findings are based on data from Denmark, where researchers analyzed how many new moms filled a prescription for a GLP-1 drug within six months of giving birth
Even if you meet the diagnostic criteria weve discussed, you would not be indicated for a weight loss peptide if you are: Pregnant Animal studies show that the offspring of pregnant subjects exposed to GLP-1 RAs may develop skeletal abnormalities, have a low birth weight, and exhibit substandard growth.23 Although no congenital malformations have been widely identified in humans, people who are pregnant or planning to become pregnant are advised to forgo or end their GLP-1 RA treatment
Soluble oligomers of amyloid-beta cause changes in redox state, DNA methylation, and gene transcription by inhibiting EAAT3 mediated cysteine uptake
It just creates blind spots, and puts health plans and providers at risk of falling behind
Follow-Up and Monitoring : Regular follow-up appointments are essential to monitor the patients response to adjustments in treatment and to reassess the management plan as needed
